Vfend and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Vfend (voriconazole), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Zosyn, and have Hiv infection.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Vfend. It is created by eHealthMe based on reports of 12,081 people who have side effects when taking Vfend from the FDA, and is updated regularly.

What is Vfend?

Vfend has active ingredients of voriconazole. It is often used in aspergillosis. eHealthMe is studying from 12,128 Vfend users. Check the latest studies of Vfend.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 2,007 drugs and 1,973 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

On Jul, 10, 2026

12,081 people reported to have side effects when taking Vfend.
Among them, 17 people (0.14%) have Dermatitis - atopic.

Among these 17 people:

How long have people been on Vfend when they have Dermatitis - atopic? *

What is the gender of people who have Dermatitis - atopic when taking Vfend? *

female: 18.75 %
male: 81.25 %

What is the age of people who have Dermatitis - atopic when taking Vfend? *

What are other drugs people take besides Vfend? *

What are other side effects people have besides Dermatitis - atopic? *

Anaemia (lack of blood): 8 people, 47.06%
Drug Hypersensitivity: 7 people, 41.18%
Low Density Lipoprotein Increased (cholesterol increased in blood): 7 people, 41.18%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 41.18%
Drug Eruption (adverse drug reaction of the skin): 7 people, 41.18%
Hepatic Function Abnormal: 7 people, 41.18%
Herpes Zoster: 7 people, 41.18%
Renal Impairment (severely reduced kidney function): 7 people, 41.18%
Upper Respiratory Tract Inflammation: 7 people, 41.18%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 5 people, 29.41%

What are the existing conditions these people have? *

Hiv Infection: 8 people, 47.06%
Pneumonia: 7 people, 41.18%
Cytomegalovirus Infection: 7 people, 41.18%
Pulmonary Mycosis (lung infection caused by yeast-like fungi): 6 people, 35.29%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 11.76%
Candidiasis (candidiasis or thrush is a fungal infection): 2 people, 11.76%
Pneumonia Fungal: 1 person, 5.88%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%
Hepatitis B: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Vfend and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vfend:

Vfend (12,128 reports)

Browse all side effects of Vfend:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (2,007 drugs)

Browse all the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,973 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on voriconazole (the active ingredients of Vfend) and Vfend (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.